GlassScriptPhysician profile
Ryan Carl Hill
NPI 1073709077
$7,478.23
in general payments reported to CMS, 2019-2025
30 companies · $1,026 in 2025
The $1,026 reported for 2025 was more than what 94% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $411 · 2020: $638 · 2021: $1,723 · 2022: $1,440 · 2023: $970 · 2024: $1,270 · 2025: $1,026.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,266.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,265.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $2,598.40 | 2019-2025 | Wavewriter Alpha Prime 16, General - Pain Management, General - Therapies |
| Medtronic, INC. | $986.58 | 2021-2025 | Inceptiv, Intellis Adaptivestim, Kyphon Express II Kyphopak Tray |
| Nevro Corp. | $981.57 | 2020-2024 | Senza |
| Collegium Pharmaceutical, INC. | $617.34 | 2021-2025 | Belbuca, Xtampza |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $541.47 | 2020-2025 | Relistor |
| Abbott Laboratories | $432.39 | 2019-2023 | Eterna, Penta |
| Biodelivery Sciences International, INC. | $171.54 | 2020-2021 | |
| Globus Medical, INC. | $164.79 | 2025 | Senza |
| Stryker Corporation | $162.49 | 2024 | Blueprint Patient Specific Instrumentation |
| Forte Bio-Pharma LLC | $148.50 | 2021-2025 | Prolate, Nalocet, Tanlor |
| Depuy Synthes Sales INC. | $97.74 | 2024 | Inhance |
| Scilex Pharmaceuticals INC. | $52.41 | 2021-2023 | Ztlido |
| Redhill Biopharma INC. | $49.60 | 2020-2021 | |
| Vertos Medical, INC. | $48.03 | 2022 | |
| Teleflex LLC | $46.17 | 2022 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Painteq LLC | $41.27 | 2024 | Painteq |
| Si-Bone, INC. | $36.82 | 2024 | |
| Hikma Pharmaceuticals USA | $35.00 | 2022 | |
| Saluda Medical Americas, INC. | $34.18 | 2025 | Evoke |
| Spr Therapeutics, INC | $33.34 | 2025 | Sprint Pns System |
| Chiesi USA, INC. | $25.58 | 2019 | |
| Amgen INC. | $24.93 | 2020-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $24.65 | 2024 | Jardiance |
| Pfizer INC. | $20.73 | 2020 | |
| Kiniksa Pharmaceuticals International, Plc | $20.69 | 2024 | Arcalyst |
| Zyla Life Sciences, INC. | $20.58 | 2020 | |
| Vertex Pharmaceuticals Incorporated | $20.13 | 2025 | |
| Avanos Medical | $15.28 | 2022 | |
| Radius Health, INC. | $13.92 | 2021 | |
| Grt US Holding, INC. | $12.11 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Hill listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.